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Purpose/Objective: Cancer is the most common cause of 
death at ages 1-16. Approximately 300 children annually 
develop a malignancy in Sweden and one third of these are 
brain tumors. Modern therapy cures 75% of all children struck 
with cancer. However, the tough therapy, including 
radiotherapy, has both acute and long-lasting, effects. Even 
low doses of ionizing radiation to the brain can cause 
intellectual impairment as well as perturbed growth and 
puberty.  
Hyperthermia has gained a reputation of effective radio- and 
chemo-sensitizer, which has minimal side effects. Our 
hypothesis is that the focused microwave hyperthermia will 
allow a reduced radiation dose with maintained treatment 
outcome and no added toxicity. A novel antenna applicator 
for microwave hyperthermia allowing treatment of deep 
brain tumors has been designed. The goal of this study is to 
investigate the feasibility of focused heating deep inside the 
head. 
Materials and Methods: The number and position of antennas 
was determined by using the homogeneous SAM (Specific 
Anthropomorphic Mannequin) head model. The focusing 
abilities of the resulting applicator were then investigated 
using a 13-year old patient model. Specific absorption rate 
(SAR) and temperature distributions were computed for five 
realistic tumors located at various sites. Both pre-operative 
and post-operative situations were considered. 
Results: The applicator consists of 16 antennas placed around 
the head in a helmet-like set-up and operates at a frequency 
range of 430-900 MHz. The antennas are attached to a 
parametric water bolus and aligned with the head shape. 
The results show considerable target coverage in terms of 
SAR in the target region with a remarkably low SAR in critical 
tissues in both pre- and postoperative cases. The 
postoperative situation showed more favorable heating of the 
target volume as exemplified by temperature distribution in 
meduloblastoma shown in Figure 1. The achieved median 
temperature was 42°C while for the preoperative cases, 
target temperatures were up to 3 degrees lower due to 
relatively high perfusion of the target.  
 
 
Conclusions: The newly designed system is capable of 
selective intracranial heating in postoperative scenarios. For 
preoperative applications, further improvements in heating 
techniques are currently investigated.  
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Purpose/Objective: For high risk abdominal neuroblastoma, 
traditional paediatric radiotherapy dogma dictates that an 
irradiated vertebral body (VB) should be fully included within 
the planning target volume (PTV) to ensure even dose 
distribution and avoid asymmetric growth. However, clinical 
experience indicates that beyond a threshold VB dose which 
abolishes or minimises growth, VB dose inhomogeneity is less 
relevant. Our objective was to assess whether dose painting 
using VMAT with a simultaneous integrated boost (SIB) can 
improve renal sparing.  
Materials and Methods: Five cases of lateralised disease 
previously treated with fixed-fields were replanned with dual 
arc VMAT using conventional (VMAT-conv) and SIB (VMAT-SIB) 
techniques. PTV21 was the original, unadjusted PTV (clinical 
target volume +1cm). Adjacent VB were taken as those ≤1cm 
from PTV21. For VMAT-conv, 21 Gy in 14 fractions was 
prescribed to PTV21 and adjacent VB. For VMAT-SIB, 21 Gy 
was prescribed to PTV21, but adjacent VB were constrained 
to < 20% dose gradient, or >15 Gy minimum. Organ at risk 
(OAR) dose constraints were from the SIOPEN HR-NBL-1 
protocol. Kidney doses were reduced iteratively to control 
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the shoulder, intermediate and high dose ranges of the dose 
volume histogram until coverage was tight but not 
compromised by ICRU 83. Homogeneity index was calculated 
as (D2%-D98%)/D50%. Two-sided paired sample t-tests were 
used to assess statistical significance, taken as p 
Results: The mean volume prescribed 21 Gy was 398 cm3 
(range 259-611) for VMAT-conv and 318 cm3 (range 213-526) 
for VMAT-SIB plans. By using VMAT-SIB, 72-78% of the volume 
of the VB at the level of the kidneys was prescribed 15 Gy 
rather than 21 Gy. PTV minimum, mean, maximum, D2% and 
D98% doses did not differ significantly between the plans. 
Both techniques achieved clinically acceptable plans. As 
expected, VMAT-SIB plans had greater VB dose 
inhomogeneity. VMAT-SIB allowed reductions in some 
combined (right plus left) and contralateral kidney doses 
(Table 1). Contralateral kidney V15, V18 and V21, combined 
kidney V12, V15 and V18, and ipsilateral kidney and liver 
doses were similar. The renal sparing achieved in at least 3 of 
5 cases was judged to be clinically significant, most apparent 
at the 5 Gy level; contralateral kidney V5 was reduced from 
[24, 31, 95, 94, 81]% to [13, 6, 11, 20, 13]% in the 5 cases. An 
example is shown in Figure 1. 
 
 
 
 
 
Conclusions: Dose painting with VMAT-SIB for high risk 
abdominal neuroblastoma is feasible. Controlled dose 
inhomogeneity in the VB can improve contralateral kidney 
sparing without increasing expected risks of asymmetric 
growth. The absolute differences between the techniques 
can be small and work is ongoing to identify factors that 
predict patients most likely to benefit. The benefit of 
sizeable reductions in the volume of contralateral kidney 
receiving 5 Gy is not well described, but may be clinically 
significant. 
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Purpose/Objective: To retrospectively compare VMAT and 
IMRT for cranio-spinal irradiation (CSI) of standard-risk 
medulloblastoma (MB) paediatric patients and to estimate 
their impact on the potential clinical benefit.  
Materials and Methods: We selected 10 paediatric MB 
patients, with a median age of 7.5 years, who received CSI 
with a dose of 23.4 Gy, followed by a boost to posterior fossa 
up to 55.8 Gy, with 1.8 Gy/fraction. 
